| STEX |
Streamex Corp. |
Lekstrom Morgan Lee |
Director
10% Owner
|
2026-02-03 |
P - A |
23,500 |
3.06 |
71,910.00 |
102,500 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,178 |
21.94 |
47,785.32 |
641,685 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,177 |
21.94 |
47,763.38 |
641,682 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,178 |
21.94 |
47,785.32 |
641,685 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,177 |
21.94 |
47,763.38 |
641,682 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,178 |
21.94 |
47,785.32 |
641,685 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,177 |
21.94 |
47,763.38 |
641,682 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,178 |
21.94 |
47,785.32 |
641,685 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,177 |
21.94 |
47,763.38 |
641,682 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,178 |
21.94 |
47,785.32 |
641,685 |
| SRZN |
Surrozen, Inc./DE |
TCG Crossover Fund III, L.P. |
|
2026-02-03 |
P - A |
2,177 |
21.94 |
47,763.38 |
641,682 |
| RPID |
RAPID MICRO BIOSYSTEMS, INC. |
Tammenoms Bakker Juliet |
|
2026-02-03 |
S - D |
27,500 |
4.24 |
116,641.25 |
49,000 |
| ALLY |
Ally Financial Inc. |
Timmerman Douglas R. |
|
2026-02-03 |
A - A |
41,135 |
42.30 |
1,740,010.50 |
517,302 |
| TVTX |
Travere Therapeutics, Inc. |
REED ELIZABETH E |
|
2026-02-03 |
S - D |
7,175 |
32.12 |
230,461.00 |
108,205 |
| TVTX |
Travere Therapeutics, Inc. |
ROTE WILLIAM E. |
|
2026-02-03 |
S - D |
12,446 |
32.87 |
409,100.02 |
109,087 |
| TVTX |
Travere Therapeutics, Inc. |
Dube Eric M |
|
2026-02-03 |
S - D |
66,452 |
32.06 |
2,130,451.12 |
466,521 |
| TVTX |
Travere Therapeutics, Inc. |
Dube Eric M |
|
2026-02-03 |
S - D |
33,635 |
32.70 |
1,099,864.50 |
432,886 |
| TVTX |
Travere Therapeutics, Inc. |
Heerma Peter |
|
2026-02-03 |
S - D |
7,310 |
32.12 |
234,797.20 |
131,823 |
| TVTX |
Travere Therapeutics, Inc. |
Calvin Sandra |
|
2026-02-03 |
S - D |
4,333 |
32.12 |
139,175.96 |
49,080 |
| TVTX |
Travere Therapeutics, Inc. |
Inrig Jula |
|
2026-02-03 |
S - D |
6,956 |
32.12 |
223,426.72 |
107,485 |
| TVTX |
Travere Therapeutics, Inc. |
Cline Christopher R. |
|
2026-02-03 |
S - D |
7,242 |
32.12 |
232,613.04 |
112,971 |
| CLS |
CELESTICA INC |
Tzevelekis Theodoros |
|
2026-02-03 |
A - A |
1,263 |
0.00 |
0.00 |
1,263 |
| UMBF |
UMB FINANCIAL CORP |
Gallagher Kevin Charles |
Director
|
2026-02-03 |
S - D |
388 |
129.30 |
50,168.40 |
12,488 |
| UTHR |
UNITED THERAPEUTICS Corp |
MALCOLM JAN |
|
2026-02-03 |
S - D |
50 |
474.23 |
23,711.50 |
270 |
| VIAV |
VIAVI SOLUTIONS INC. |
Staley Gary W |
Officer
|
2026-02-03 |
S - D |
20,742 |
25.92 |
537,632.64 |
182,810 |